/ /

Vanessa Caceres
Metabolome-wide study finds link between androgen metabolism and dry eye
A metabolomics study found a link between dry eye disease and androgen metabolism in females.
Lutein, zeaxanthin assist in visual function both early, later in life
A diet that contains lutein and zeaxanthin—or supplementation with these two carotenoids—appears to benefit healthy vision throughout life.
Diabetes drug could reduce the risk of open-angle glaucoma
Use of metformin, a drug therapy for the treatment of diabetes, was found to be associated with reduced risk of adult-onset, open-angle glaucoma in a recent study.
Genotype-directed therapy may help patients with moderate AMD
Genotype-directed therapy may help patients with moderate AMD
Genotyping reveals that certain patients with moderate age-related macular degeneration may benefit more from the AREDS formulation than others.
Nanophotonics-based implant may enable at-home IOP monitoring
A nanophotonics-based device implanted in the eye may one day enable patients with glaucoma to monitor their IOP from home.
SLT without gonioscopy lens successful
Selective laser trabeculoplasty (SLT) without the use of a gonioscopy lens was performed successfully and still decreased IOP over 6 months, said Michael Belkin, MD.
Curiosity-driven research leads to award-winning discoveries
Researchers should continue to explore offhand leads or spur-of-the-moment ideas, said 2005 Nobel laureate Barry Marshall, FRACP, FRS, FAA. These very actions have sometimes led to world-changing, award-winning research.
Predictors for the number of AMD injections
Retinal angiomatous proliferation (RAP) lesions, treatment with ranibizumab, the absence of subretinal fluid, and the absence of subretinal pigment epithelium fluid (RPE) were associated with fewer injections for neovascular age-related macular degeneration (AMD) among participants from the Comparison of AMD Treatments Trials (CATT), said Daniel F. Martin, MD.
Retinal inflammation: Novel drug delivery
Nanomedicine that targets activated microglia and neuro-inflammation may one day be a potential therapy for age-related macular degeneration (AMD), diabetic retinopathy, and other eye diseases, said Rangaramanujam Kannan, PhD.


View Results